Rhinosinusitis future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
===Medical therapy=== | |||
*Topical corticosteroids with improved delivery route: | |||
*Monoclonal antibodies against inflammatory agents: | |||
*Identifying predictors of patient compliance and treatment response: | |||
*Alternative or complementary therapies for surgery in recurrent cases: | |||
*Finding a "cure" for chronic rhinosinusitis: This could be possible by finding a method to correct the immune dysfunction in the patients. | |||
==References== | ==References== | ||
Revision as of 16:43, 4 December 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Future or Investigational Therapies
Medical therapy
- Topical corticosteroids with improved delivery route:
- Monoclonal antibodies against inflammatory agents:
- Identifying predictors of patient compliance and treatment response:
- Alternative or complementary therapies for surgery in recurrent cases:
- Finding a "cure" for chronic rhinosinusitis: This could be possible by finding a method to correct the immune dysfunction in the patients.